Cocrystal systems of pharmaceutical interest: 2011

Crystal Growth and Design

Volumn 12, Issue 11, 2012, Pages 5823-5832

  Brittain, Harry G ^a  

^a Center for Pharmaceutical Physics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CO-CRYSTALS; COCRYSTALLIZATION; DRAFT GUIDANCE; DRUG EVALUATION; FOOD AND DRUG ADMINISTRATION; SUBJECT MATTERS;

INFORMATION RETRIEVAL SYSTEMS;

EID: 84868699254     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg301114f     Document Type: Article

References (70)

1. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. Pharmaceutical Cocrystals J. Pharm. Sci. 2006, 95, 499-516
2. Shan, N.; Zaworotko, M. J. The Role of Cocrystals in Pharmaceutical Science Drug Discovery Today 2008, 13, 440-446
3. Friščić, T.; Jones, W. Benefits of Cocrystallization in Pharmaceutical Materials Science: an Update J. Pharm. Pharmacol. 2010, 62, 1547-1559
4. Stahly, G. P. A Survey of Cocrystals Reported Prior to 2000 Cryst. Growth Des. 2009, 9, 4212-4229
5. Brittain, H. G. Cocrystal Systems of Pharmaceutical Interest: 2007-2008. Profiles of Drug Substances, Excipients, and Related Methodology; Brittain, H. G., Ed.; Elsevier Academic Press: Amsterdam, 2010; Vol. 35, pp 373-390.
6. Brittain, H. G. Cocrystal Systems of Pharmaceutical Interest: 2009. Profiles of Drug Substances, Excipients, and Related Methodology; Brittain, H. G., Ed.; Elsevier Academic Press: Amsterdam, 2010; Vol. 36, pp 361-381.
7. Brittain, H. G. Cocrystal Systems of Pharmaceutical Interest: 2010 Cryst. Growth Des. 2012, 12, 1046-1054
8. Aakeröy, C. B.; Salmon, D. J. Building Cocrystals with Molecular Sense and Supramolecular Sensibility CrystEngComm 2005, 7, 439-448
9. Qjao, N.; Li, M.; Schlindwein, W.; Malek, N.; Davies, A.; Trappitt, G. Pharmaceutical Cocrystals: An Overview Int. J. Pharm. 2011, 419, 1-11
10. Chen, J.; Sarms, B.; Evans, J. M. B.; Myerson, A. S. Pharmaceutical Crystallization Cryst. Growth Des. 2011, 11, 887-895
11. Chieng, N.; Rades, T.; Aaltonen, J. An Overview of Recent Studies on the Analysis of Pharmaceutical Polymorphs J. Pharm. Biomed. Anal. 2011, 55, 618-644
12. Thomas, J. M. Crystal Engineering: Origins, Early Adventures and some Current Trends CrystEngComm 2011, 13, 4304-4306
13. Biradha, K.; Su, C.-Y.; Vittal, J. J. Recent Developments in Crystal Engineering Cryst. Growth Des. 2011, 11, 875-886
14. Desiraju, G. R. Reflections on the Hydrogen Bond in Crystal Engineering Cryst. Growth Des. 2011, 11, 896-898
15. Desiraju, G. R. A Bond by Any Other Name Angew. Chem. Int. Ed. 2011, 50, 52-59
16. Mohamed, S.; Tocher, D. A.; Price, S. L. Computational Prediction of Salt and Cocrystal Structures - Does a Proton Position Matter? Int. J. Pharm. 2011, 418, 187-198
17. Hathwar, V. R.; Thakus, T. S.; Guru Row, T. N. Transferability of Multipole Charge Density Parameters for Supramolecular Synthons: A New Tool for Quantitative Crystal Engineering Cryst. Growth Des. 2011, 11, 616-623
18. Seaton, C. C. Creating Carboxylic Acid Cocrystals: The Application of Hammett Substitution Constants CrystEngComm 2011, 13, 6583-6592
19. Anderson, K. M.; Probert, M. R.; Goeta, A. E.; Steed, J. W. Size Does Matter - The Contribution of Molecular Volume, Shape and Flexibility to the Formation of Cocrystals and Structures with Z′ > 1 CrystEngComm 2011, 13, 83-87
20. Babu, N. J.; Nangia, A. Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals Cryst. Growth Des. 2011, 11, 2662-2679
21. Lee, H.-G.; Zhang, G. Z.; Flanagan, D. R. Cocrystal Intrinsic Dissolution Behavior using a Rotating Disk J. Pharm. Sci. 2011, 100, 1736-1744
22. Huang, N.; Rodríguez-Hornedo, N. Engineering Cocrystal Thermodynamic Stability and Eutectic Points by Micellar Solubilization and Ionization CrystEngComm 2011, 13, 5409-5422
23. MAX by Micellar Solubilization J. Pharm. Sci. 2011, 100, 5219-5234
24. Seaton, C. C.; Parkin, A. Making Benzamide Cocrystals with Benzoic Acids: The Influence of Chemical Structure Cryst. Growth Des. 2011, 11, 1502-1511
25. Brittain, H. G. Vibrational Spectroscopic Studies of Cocrystals and Salts. 4. Cocrystal Products formed by Benzylamine, α-Methylbenzylamine, and their Chloride Salts Cryst. Growth Des. 2011, 11, 2500-2509
26. Mukherjee, A.; Grobelny, P.; Thakur, T. S.; Desiraju, G. R. Polymorphs, Pseudo-polymorphs, and Cocrystals of Orcinol: Exploring the Structural Landscape with High Throughput Crystallography Cryst. Growth Des. 2011, 11, 2637-2653
27. Abourahma, H.; Cocuzza, D. S.; Melendez, J.; Urban, J. M. Pyrazinamide Cocrystals and the Search for Polymorphs CrystEngComm 2011, 13, 6442-6450
28. Braga, D.; Grepioni, F.; Lamprinti, G. I.; Maini, L.; Turrina, A. Ionic Cocrystals of Organic Molecules with Metal Halides: A New Prospect in the Solid Formulation of Active Pharmaceutical Ingredients Cryst. Growth Des. 2011, 11, 5621-5627
29. Aakeröy, C. B.; Chopade, P. D.; Desper, J. Avoiding "Synthon Crossover" in Crystal Engineering with Halogen Bonds and Hydrogen Bonds Cryst. Growth Des. 2011, 11, 5333-5336
30. Friščić, T.; Reid, D. G.; Day, G. M.; Duer, M. J.; Jones, W. Effect of Fluorination on Molecular Conformation in the Solid State: Tuning the Conformation of Cocrystal Formers Cryst. Growth Des. 2011, 11, 972-981
31. Mohammad, M. A.; Alhalaweh, A.; Velaga, S. P. Hansen Solubility Parameter as a Tool to Predict Cocrystal Formation Int. J. Pharm. 2011, 407, 63-71
32. Bag, P. P.; Patni, M.; Reddy, C. M. A Kinetically Controlled Crystallization Process for Identifying New Cocrystal Forms: Fast Evaporation of Solvent from Solutions to Dryness CrystEngComm 2011, 13, 5650-5652
33. Gonnade, R. G.; Iwama, S.; Mori, Y.; Takahashi, H.; Tsue, H.; Tamura, R. Observation of Efficient Preferential Enrichment Phenomenon for a Cocrystal of (DL)-Phenylalanine and Fumaric Acid under Nonequilibrium Crystallization Conditions Cryst. Growth Des. 2011, 11, 607-615
34. Yu, Z. Q.; Chow, P. S.; Tan, R. B. H.; Ang, W. H. Supersaturation Control in Cooling Polymorphic Cocrystallization of Caffeine and Glutaric Acid Cryst. Growth Des. 2011, 11, 4525-4532
35. Di Profio, G.; Grosso, V.; Caridi, A.; Caliandro, R.; Guagliardi, A.; Chita, G.; Curcio, E.; Drioli, E. Direct Production of Carbamazepine-Saccharin Cocrystals from Water/Ethanol Solvent Mixtures by Membrane-Based Crystallization Technology CrystEngComm 2011, 13, 5670-5673
36. Trask, A. V.; Motherwell, D. S.; Jones, W. Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach Top. Curr. Chem. 2005, 254, 41-70
37. Bysouth, S. R.; Bis, J. A.; Igo, D. Cocrystallization via Planetrary Milling: Enhancing Throughput of Solid-State Screening Methods Int. J. Pharm. 2011, 411, 169-171
38. Ibrahim, A. Y.; Forbes, R. T.; Blagden, N. Spontaneous Crystal Growth of Cocrystals: The Contribution of Particle Size Reduction and Convection Mixing of the Coformers CrystEngComm 2011, 13, 1141-1152
39. Good, D.; Miranda, C.; Rodríguez-Hornedo, N. Dependence of Cocrystal Formation and Thermodynamic Stability on Moisture Sorption by Amorphous Polymer CrystEngComm 2011, 13, 1181-1189
40. Urbanus, J.; Roelands, C. P. M.; Mazurek, J.; Verdoes, D.; ter Horst, J. H. Electrochemically Induced Cocrystallization for Product Removal CrystEngComm 2011, 13, 2817-2819
41. Gao, Y.; Zu, H.; Zhang, J. Enhanced Dissolution and Stability of Adefovir Dipivoxil by Cocrystal Formation J. Pharm. Pharmacol. 2011, 63, 483-490
42. Gryl, M.; Krawczuk-Pantula, A.; Stadnicka, K. Charge-Density Analysis in Polymorphs of Urea-Barbituric Acid Cocrystals Acta Crystallogr. 2011, B67, 144-154
43. Majunder, M.; Buckton, G.; Rawlinson-Malone, C.; Williams, A. C.; Spillman, M. J.; Shankland, N.; Shankland, K. A Carbamazepine-Indomethacin (1:1) Cocrystal Produced by Milling CrystEngComm 2011, 13, 6327-6328
44. Buanz, A. B. M.; Parkinson, G. N.; Gaisford, S. Characterization of Carbamazepine-Nicatinamide Cocrystal Polymorphs with Rapid Heating DSC and XRPD Cryst. Growth Des. 2011, 11, 1177-1181
45. Schultheiss, N.; Roe, M.; Boerrigter, X. M. Cocrystals of Nutraceutical p -Coumaric Acid with Caffeine and Theophylline: Polymorphism and Solid-State Stability Explored in Detail using their Crystal Graphs CrystEngComm 2011, 13, 611-619
46. Tsutsumi, H.; Kinoshita, Y.; Sato, T.; Ishizu, T. Configurational Studies of Complexes of Various Tea Catechins and Caffeine in Crystal State Chem. Pharm. Bull Des. 2011, 59, 1008-1015
47. Sanphui, P.; Goud, N. R.; Khandavilli, U. B. R.; Nangia, A. Fast Dissolving Curcumin Cocrystals Cryst. Growth Des. 2011, 11, 4135-4145
48. Báthori, N. B.; Lemmerer, A.; Venter, G. A.; Bourne, S. A.; Caira, M. R. Pharmaceutical Cocrystals with Isonicotinamide - Vitamin B3, Clofibric Acid, and Diclofenac - and Two Isonicotinamide Hydrates Cryst. Growth Des. 2011, 11, 75-87
49. Evora, A. O. L.; Castro, R. A. E.; Maria, T. M. R.; Rosado, M. T. S.; Silva, M. R.; Beja, A. M.; Canotilho, J.; Eusebio, M. E. S. Pyrazinamide- Diflunisal: A New Dual Drug Cocrystal Cryst. Growth Des. 2011, 11, 4780-4788
50. Fábián, L.; Hamuk, N.; Eccles, K. S.; Moynihan, H. A.; Maguire, A. R.; McCausland, L.; Lawrence, S. E. Cocrystals of Fenamic Acids with Nicotinamide Cryst. Growth Des. 2011, 11, 3522-3528
51. Kastelic, J.; Lah, N.; Kikelj, D.; Leban, I. A 1:1 Cocrystal of Fluconazole with Salicylic Acid Acta Crystallogr. 2011, C67, o370-o372
52. Alhalweh, A.; Sokolowski, A.; Rodríguez-Hornedo, N.; Velaga, S. P. Solubility Behavior and Solution Chemistry of Indomethacin Cocrystals in Organic Solvents Cryst. Growth Des. 2011, 11, 3923-3929
53. Grobelny, P.; Mukherjee, A.; Desiraju, G. R. Drug-Drug Cocrystals: Temperature-Dependent Proton Mobility in the Molecular Complex of Isoniazid with 4-Aminosalicylic Acid CrystEngComm 2011, 13, 4358-4364
54. Lemmerer, A.; Bernstein, J.; Kahlenberg, V. Covalent Assistance in Supramolecular Synthesis: in situ Modification and Masking of the Hydrogen Bonding Functionality of the Supramolecular Reagent Isoniazid in Cocrystals CrystEngComm 2011, 13, 5692-5708
55. Chadha, R.; Saini, A.; Arora, P.; Jain, D. S.; Dasgupta, A.; Guru Row, T. N. Multicomponent Solids of Lamotrigine with some Selected Coformers and their Characterization by Thermoanalytical, Spectroscopic, and X-Ray Diffraction Methods CrystEngComm 2011, 13, 6271-6284
56. Cheney, M. L.; Weyna, D. R.; Shan, N.; Hanna, M.; Wojtas, L. Coformer Selection in Pharmaceutical Cocrystal Development: A Case Study of a Meloxicam Aspirin Cocrystal that Exhibits Enhanced Solubility and Pharmacokinetics J. Pharm. Sci. 2011, 100, 2172-2181
57. Tsutsumi, S.; Iida, M.; Tada, N.; Kojima, T.; Ikeda, Y.; Moriwaki, T.; Higashi, K.; Moribe, K.; Yamamoto, K. Characterization and Evaluation of Miconazole Salts and Cocrystals for Improved Physicochemical Properties Int. J. Pharm. 2011, 421, 230-236
58. Castro, R. A. E.; Ribeiro, J. D. B.; Maria, T. M. R.; Silva, M. R.; Yeste-Vivas, C.; Canotilho, J.; Eusébio, M. E. S. Naproxen Cocrystals with Pyridinecarboxamide Isomers Cryst. Growth Des. 2011, 11, 5396-5404
59. Cherukuvada, S.; Babu, N. J.; Nangia, A. Nitrofurantoin- p -Aminobenzoic Acid Cocrystal: Hydration Stability and Dissolution Rate Studies J. Pharm. Sci. 2011, 100, 3233-3244
60. Vangala, V. R.; Chos, P. S.; Tan, R. B. H. Characterization, Physicochemical and Photo-Stability of a Cocrystal Involving an Antibiotic Drug, Nitrofurantoin, and 4-Hydroxy-benzoic Acid CrystEngComm 2011, 13, 759-762
61. 2O CrystEngComm 2011, 13, 6361-6364
62. Elbagerma, M. A.; Edwards, H. G. M.; Munshi, T.; Schowen, I. J. Identification of a New Cocrystal of Citric Acid and Paracetamol of Pharmaceutical Relevance CrystEngComm 2011, 13, 1877-1884
63. Bethune, S. J.; Schultheiss, N.; Henck, J.-O. Improving the Poor Aqueous Solubility of Nutraceutical Compound Pterostilbene through Cocrystal Formation Cryst. Growth Des. 2011, 11, 2817-2823
64. Khan, M.; Enkelmann, V.; Brunklaus, G. Heterosynthon Mediated Tailored Synthesis of Pharmaceutical Complexes: A Solid-State NMR Approach CrystEngComm 2011, 13, 3213-3223
65. Paluch, K. J.; Tajber, L.; Elcoate, C. J.; Corrigan, O. J.; Lawrence, S. E.; Healy, A. M. Solid-State Characterization of Novel Active Pharmaceutical Ingredients: Cocrystal of a Salbutamol Hemiadipate Salt with Adipic Acid (2:1:1) and Salbutamol Hemisuccinate Salt J. Pharm. Sci. 2011, 100, 3268-3283
66. Ghosh, S.; Bag, P. P.; Reddy, C. M. Cocrystals of Sulfamethazine with some Carboxylic Acids and Amides: Coformer Assisted Tautomerism in an Active Pharmaceutical Ingredient and Hydrogen Bond Competition Study Cryst. Growth Des. 2011, 11, 3489-3503
67. Lu, J.; Cruz-Cabeza, J.; Rohani, S.; Jennings, M. C. A 2:1 Sulfamethazine-Theophylline Cocrystal Exhibiting Two Tautomers of Sulfamethazine Acta Crystallogr. 2011, C67, o306-o309
68. Center for Drug Evaluation and Research. 2011. Regulatory Classification of Pharmaceutical Co-Crystals. United States Food and Drug Administration (www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM281764.pdf; last accessed 8/1/2012).
69. Aitipamula, S.; Banerjee, R.; Bansal, A. K.; Biradha, K.; Cheney, M. L.; Choudhury, A. R.; Desiraju, G. R.; Dikundwar, A. G.; Dubey, R.; Duggirala, N.; Ghogale, P. P.; Ghosh, S.; Goswami, K; Goud, N. R.; Jetti, R. R. K. R.; Karpinski, P.; Kaushik, P.; Kumar, D.; Kumar, V.; Moulton, B.; Mukherjee, A.; Mukherjee, G.; Myerson, A. S.; Puri, V.; Ramanan, A.; Rajamannar, T.; Reddy, C. M.; Rodriguez-Hornedo, N.; Rogers, R. D.; Guru Row, T. N.; Sanphui, P.; Shan, N.; Shete, G.; Singh, A.; Sun, C. C.; Swift, J. A.; Thaimattam, R.; Thakur, T. S.; Thaper, R. K.; Thomas, S. P.; Tothadi, S.; Vangala, V. R.; Variankaval, N.; Vishweshwar, P.; Weyna, D. R.; Zaworotko, M. J. Polymorphs, Salts, and Cocrystals: Whats in a Name? Cryst. Growth Des. 2012, 12, 2147-2152
70. Comments of 2011-31022 Draft Guidance for Industry on Regulatory Classification of Pharmaceutical Co-Crystals. (federal.eregulations.us/comment/ list/c42d77d3-dc53-4c16-976d-9331c5c8fc1.html; last accessed 8/1/2012).